C4 Therapeutics CCCC
NASDAQ CCCC
$3.33 +0.20 (+6.39%)
At close: Sep 30, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Shares Outstanding (Entity) (2019 - 2026)

Updated

C4 Therapeutics (CCCC) posted Shares Outstanding (Entity) of 122.91 million for Q2 2026, up 73.1% from 71.01 million a year earlier and up 18.1% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

For FY2025, C4 Therapeutics' Shares Outstanding (Entity) came in at 96.91 million, up 37.2% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for six consecutive years, with a five-year compound annual growth rate of 53.5% (FY2020 to FY2025).
  • In prior years, C4 Therapeutics' Shares Outstanding (Entity) was 70.63 million in FY2024 (+42.3%), 49.64 million in FY2023 (+1.4%), 48.97 million in FY2022 (+0.6%) and 48.69 million in FY2021 (+328.2%).
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2019.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 19 quarters, with growth averaging 31.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.4% (Q2 2023) to 328.2% (Q4 2021).
  • According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 104.04 million (Q1 2026), 96.91 million (Q4 2025) and 74.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 2.41 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 1.77 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 253.35 Mn
10 C4 Therapeutics 384.70 Mn -545.06 Mn - 122.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 122.91 Mn
Mar 31, 2026 104.04 Mn
Dec 31, 2025 96.91 Mn
Sep 30, 2025 74.17 Mn
Jun 30, 2025 71.01 Mn
Mar 31, 2025 70.99 Mn
Dec 31, 2024 70.63 Mn
Sep 30, 2024 70.56 Mn
Jun 30, 2024 68.82 Mn
Mar 31, 2024 68.78 Mn
Dec 31, 2023 49.64 Mn
Sep 30, 2023 49.26 Mn
Jun 30, 2023 49.07 Mn
Mar 31, 2023 49.05 Mn
Dec 31, 2022 48.97 Mn
Sep 30, 2022 48.95 Mn
Jun 30, 2022 48.88 Mn
Mar 31, 2022 48.75 Mn
Dec 31, 2021 48.69 Mn
Sep 30, 2021 48.59 Mn
API Access

C4 Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CCCC&period=max&api_key=YOUR_API_KEY